Radboud Institute for Molecular Life Sciences (RIMLS)
The Radboud Institute for Molecular Life Sciences (RIMLS) main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. We aim to improve clinical practice and public health by:
- generating basic knowledge in the molecular medical science
- translating our gained knowledge into clinical applications, and into diagnostic, therapeutic and personalized treatment strategies
- training and exposing researchers of all levels to societal-relevant multidisciplinary research questions along the theme of understanding the molecular basis of disease.
Research domains and themes
The RIMLS accommodates research groups from the Radboudumc and Radboud University’s Faculty of Science. RIMLS aims to advance innovation in translational research, based on integrating diverse areas of scientific expertise within the molecular and medical sciences. In line with the Radboudumc's strategic vision to have a significant impact on healthcare, research is bundled into disease-oriented research themes from molecule-to-man in which we collaborate with the Radboud Institute for Health Sciences.
In line with the Radboudumc mission, RIMLS aims to have a significant impact on healthcare. We continuously try to bridge the gap between science and society, by, for example, being involved in the development of novel diagnostics and therapies to treat rare and common diseases. Where possible we involve patients and other stakeholders in this process. Societal impact is at the core of our ambition and our motto: Today’s molecules for Tomorrow’s medicine.
The multi-disciplinary approach to research in molecular life science is reflected in an established RIMLS Graduate School. We pride ourselves on being an international research school that offers a stimulating environment for scientists of all levels. We offer a 2-year research honours MSc degree in Molecular Mechanisms of Disease and a 4-year PhD program. In addition, the RIMLS actively participates in a post-doc platform and is committed to promoting career track models, such as the Hypatia Tenure Track.
Our innovation is advanced through a number of Technology Platforms, such as microscope and in-vivo imaging, genomics, proteomics and bioinformatics.These centers are an access point for technological expertise, high-end equipment, biobanks and combinations thereof.